What's new

RSS
Date Content
31/07/2018 Human medicines European public assessment report (EPAR): sitagliptin / metformin, Velmetia, sitagliptin / metformin, Diabetes Mellitus, Type 2, 16/07/2008, 25, Authorised (updated)
31/07/2018 Human medicines European public assessment report (EPAR): dinutuximab beta, Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), dinutuximab beta, Neuroblastoma, 08/05/2017, 4, Authorised (updated)
31/07/2018 Human medicines European public assessment report (EPAR): boceprevir, Victrelis, boceprevir, Hepatitis C, Chronic, 17/07/2011, 22, Withdrawn (updated)
31/07/2018 Minutes: CHMP ORGAM minutes for the meeting on 16 July 2018 (updated)
31/07/2018 Agenda: CHMP ORGAM agenda for the meeting on 16 July 2018 (updated)
31/07/2018 Human medicines European public assessment report (EPAR): semaglutide, Ozempic, semaglutide, Diabetes Mellitus, 07/02/2018, 1, Authorised (updated)
31/07/2018 Human medicines European public assessment report (EPAR): imatinib, Glivec, imatinib, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Gastrointestinal Stromal Tumors, Dermatofibrosarcoma, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hypereosinophilic Syndrome, 06/11/2001, 33, Authorised (updated)
31/07/2018 Herbal medicinal product: Glycini semen, Glycini semen, F: Assessment finalised (updated)
31/07/2018 Committee meeting report: COMP meeting report on the review of applications for orphan designation: July 2018 (updated)
31/07/2018 Minutes: CHMP ORGAM minutes for the meeting on 18 June 2018 (updated)